Hyperinsulinemic patients with breast cancer may be responsive to metabolism-targetin
 

Scientists at Yale Cancer Center have found that patients with breast cancer and high levels of insulin in the blood may be responsive to metabolism-targeting treatments, which in turn may improve the effectiveness of subsequent chemotherapy treatments.

More...